213 related articles for article (PubMed ID: 2934202)
1. Topographic relationship between neurofibrillary change and acetylcholinesterase rich neurons in the upper brain stem of patients with senile dementia of the Alzheimer's type and Down's syndrome.
Shortridge BA; Vogel FS; Burger PC
Clin Neuropathol; 1985; 4(6):227-37. PubMed ID: 2934202
[TBL] [Abstract][Full Text] [Related]
2. [Cerebral degeneration in Down's syndrome].
Hirabayashi K; Ikeda K; Shimokawa K; Orthner H
Folia Psychiatr Neurol Jpn; 1979; 33(1):81-96. PubMed ID: 156670
[TBL] [Abstract][Full Text] [Related]
3. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
Papasozomenos SC
Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
[TBL] [Abstract][Full Text] [Related]
4. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
Rasool CG; Svendsen CN; Selkoe DJ
Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
[TBL] [Abstract][Full Text] [Related]
5. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
Joachim CL; Morris JH; Kosik KS; Selkoe DJ
Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
[TBL] [Abstract][Full Text] [Related]
6. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
[TBL] [Abstract][Full Text] [Related]
7. Down's syndrome and Alzheimer's dementia: defining an association.
Heston LL
Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
[TBL] [Abstract][Full Text] [Related]
8. Down's syndrome in middle age. Topographical distribution and immunoreactivity of brain lesions in an autopsied patient.
Yoshimura N; Kubota S; Fukushima Y; Kudo H; Ishigaki H; Yoshida Y
Acta Pathol Jpn; 1990 Oct; 40(10):735-43. PubMed ID: 1963256
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of the nucleus basalis in Down's syndrome.
Casanova MF; Walker LC; Whitehouse PJ; Price DL
Ann Neurol; 1985 Sep; 18(3):310-3. PubMed ID: 2932050
[TBL] [Abstract][Full Text] [Related]
10. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons.
Yamamoto T; Hirano A
Ann Neurol; 1985 Jun; 17(6):573-7. PubMed ID: 4026228
[TBL] [Abstract][Full Text] [Related]
11. The neuropathology of aminergic nuclei in Alzheimer's disease.
Zweig RM; Ross CA; Hedreen JC; Steele C; Cardillo JE; Whitehouse PJ; Folstein MF; Price DL
Ann Neurol; 1988 Aug; 24(2):233-42. PubMed ID: 3178178
[TBL] [Abstract][Full Text] [Related]
12. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease.
Mesulam MM; Asuncion Morán M
Ann Neurol; 1987 Aug; 22(2):223-8. PubMed ID: 3662453
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study on histopathological findings between Alzheimer's disease and senile dementia of Alzheimer type].
Nakamura N
Rinsho Byori; 1996 Mar; 44(3):225-30. PubMed ID: 8857164
[TBL] [Abstract][Full Text] [Related]
14. [Neuropathologic study of 50 cases of senile dementia].
Fallet-Bianco C; Roudier M; Lamour Y; Davous P
Rev Neurol (Paris); 1990; 146(11):687-96. PubMed ID: 2077618
[TBL] [Abstract][Full Text] [Related]
15. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
Mesulam MM; Geula C; Morán MA
Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
[TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia.
Ball MJ; Nuttall K
Ann Neurol; 1980 May; 7(5):462-5. PubMed ID: 6446875
[TBL] [Abstract][Full Text] [Related]
17. The pathology of the human locus ceruleus.
Mann DM; Yates PO; Hawkes J
Clin Neuropathol; 1983; 2(1):1-7. PubMed ID: 6220852
[TBL] [Abstract][Full Text] [Related]
18. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
[TBL] [Abstract][Full Text] [Related]
19. Changes in Alzheimer's disease in the magnocellular neurones of the supraoptic and paraventricular nuclei of the hypothalamus and their relationship to the noradrenergic deficit.
Mann DM; Yates PO; Marcyniuk B
Clin Neuropathol; 1985; 4(3):127-34. PubMed ID: 3160517
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease and Down's syndrome.
Mann DM
Histopathology; 1988 Aug; 13(2):125-37. PubMed ID: 2971602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
